Search research articles
Contact Us
Filters
Showing results (81-90 of 103) with videos related to
Page
of 11
Sort By:
Clinical and Translational Radiation Oncology
|
January 23, 2025
Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey
Jennifer Le Guévelou, Paul Sargos, Piet Ost, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 19, 2023
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines
Sun Hyun Bae, Seok-Joo Chun, Joo-Hyun Chung, et al.
The Lancet. Oncology
|
June 15, 2025
Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial
Alison C Tree, Victoria Hinder, Andrew Chan, et al.
The Lancet. Oncology
|
September 22, 2019
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial
Douglas H Brand, Alison C Tree, Peter Ostler, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 13, 2022
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus
Thomas Zilli, Vérane Achard, Alan Dal Pra, et al.
The Lancet. Oncology
|
September 16, 2022
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial
Alison C Tree, Peter Ostler, Hans van der Voet, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 26, 2023
Development of Prostate Bed Delineation Consensus Guidelines for Magnetic Resonance Image-Guided Radiotherapy and Assessment of Its Effect on Interobserver Variability
Kobika Sritharan, Hafid Akhiat, Declan Cahill, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 9, 2026
Correlation of Biochemical Recurrence with Adverse Late Toxic Events Following Prostate Radiotherapy (COBALT Study): An Individual Patient Data Meta-Analysis of 7 Randomized Trials
John Nikitas, Parsa Jamshidian, Alison C Tree, et al.
The Lancet. Oncology
|
February 2, 2025
The interplay between acute and late toxicity among patients receiving prostate radiotherapy: an individual patient data meta-analysis of six randomised trials
John Nikitas, Parsa Jamshidian, Alison C Tree, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 31, 2020
NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer
William A Hall, Eric Paulson, Brian J Davis, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 103) with videos related to
Sort By:
Page
of 11
Clinical and Translational Radiation Oncology
|
January 23, 2025
Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey
Jennifer Le Guévelou, Paul Sargos, Piet Ost, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 19, 2023
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines
Sun Hyun Bae, Seok-Joo Chun, Joo-Hyun Chung, et al.
The Lancet. Oncology
|
June 15, 2025
Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial
Alison C Tree, Victoria Hinder, Andrew Chan, et al.
The Lancet. Oncology
|
September 22, 2019
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial
Douglas H Brand, Alison C Tree, Peter Ostler, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 13, 2022
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus
Thomas Zilli, Vérane Achard, Alan Dal Pra, et al.
The Lancet. Oncology
|
September 16, 2022
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial
Alison C Tree, Peter Ostler, Hans van der Voet, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 26, 2023
Development of Prostate Bed Delineation Consensus Guidelines for Magnetic Resonance Image-Guided Radiotherapy and Assessment of Its Effect on Interobserver Variability
Kobika Sritharan, Hafid Akhiat, Declan Cahill, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 9, 2026
Correlation of Biochemical Recurrence with Adverse Late Toxic Events Following Prostate Radiotherapy (COBALT Study): An Individual Patient Data Meta-Analysis of 7 Randomized Trials
John Nikitas, Parsa Jamshidian, Alison C Tree, et al.
The Lancet. Oncology
|
February 2, 2025
The interplay between acute and late toxicity among patients receiving prostate radiotherapy: an individual patient data meta-analysis of six randomised trials
John Nikitas, Parsa Jamshidian, Alison C Tree, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 31, 2020
NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer
William A Hall, Eric Paulson, Brian J Davis, et al.
Page
of 11